Villeurbanne, France

Nathalie Fournier

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp.. Active years: 2004-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nathalie Fournier. Retrieved from https://idiyas.com/inventor/nathalie-fournier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 25.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004-2013

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Nathalie Fournier: Innovator in Monocyte-Derived Nucleic Acids

Introduction

Nathalie Fournier is a prominent inventor based in Villeurbanne, France. She has made significant contributions to the field of biotechnology, particularly in the area of monocyte-derived nucleic acids. With a total of 4 patents to her name, her work has advanced the understanding and application of nucleic acids in various medical contexts.

Latest Patents

Fournier's latest patents focus on monocyte-derived nucleic acids and related compositions and methods. These patents describe nucleic acids encoding various monocyte-derived proteins, including purified proteins and specific antibodies. Additionally, the methods of using such compositions are provided, showcasing her innovative approach to biotechnology.

Career Highlights

Throughout her career, Nathalie Fournier has worked with notable companies such as Schering Corporation and Merck Sharp & Dohme Corp. Her experience in these organizations has allowed her to develop and refine her expertise in the field of biotechnology, contributing to her success as an inventor.

Collaborations

Fournier has collaborated with esteemed colleagues, including Elizabeth Bates and Lionel Chalus. These partnerships have further enriched her research and development efforts, leading to impactful innovations in her field.

Conclusion

Nathalie Fournier's work in monocyte-derived nucleic acids exemplifies her dedication to advancing biotechnology. Her patents and collaborations highlight her significant contributions to the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…